Text Size
32 studies found for:    " May 05, 2010":" June 04, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]

Modify this search | How to Use Search Results

Show Display Options
Download search resultsDownload the search results for:
" May 05, 2010":" June 04, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION] (32 records)
Need help? See Downloading Content for Analysis
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting Intervention Targeting Medication Adherence and Methamphetamine Use in HIV Positive Men (ACE)
Conditions: HIV Medication Adherence;   Methamphetamine Use;   Sexual Risk;   Poly-substance Use;   HIV Infections
Interventions: Behavioral: Motivational Interviewing + Cognitive Behavioral Skills Training;   Behavioral: Education Attention Control
2 Active, not recruiting DCVax Plus Poly ICLC in Healthy Volunteers
Conditions: HIV-1 Infection;   HIV Infection;   Healthy Volunteers
Interventions: Drug: DCVax-001;   Drug: Poly-ICLC;   Drug: Placebo
3 Unknown † Evaluation of a Computer-Based System Using Cell Phones for HIV People in Peru
Conditions: HIV;   Adherence;   Sexual Behavior;   HIV Infections
Intervention: Other: Cell phone intervention
4 Recruiting Computerized Brief Alcohol Intervention (BI) for Binge Drinking HIV At-Risk and Infected Women
Conditions: Hazardous Alcohol Use;   Binge Drinking;   High Risk Sexual Behaviors;   HIV Risk Reduction;   HIV Infection
Interventions: Behavioral: Computerized brief alcohol intervention with IVR booster calls;   Behavioral: Computer delivered brief alcohol intervention;   Behavioral: Attention Control
5 Completed Cardiovascular Diseases in HIV-infected Subjects (HIV-HEART Study)
Conditions: Detection of Frequency, Severity and Progression of Cardiovascular Diseases in Patients With HIV-infection.;   Effect on Cardiovascular Risk and Life Quality by Age, Gender, Classic Cardiovascular Risk Factors,;   HIV-specific Cardiovascular Risk Factors, Cardiovascular Medication, Antiretroviral Medication
Intervention:
6 Completed Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 5 Years Follow-up
Conditions: Coronary Heart Disease;   Heart Failure;   HIV;   AIDS;   Metabolic Syndrome
Intervention: Other: Comprehensive non invasive cardiovascular examination
7 Unknown † The First Failure Study
Conditions: HIV;   HIV Infections
Interventions: Drug: Darunavir, Ritonavir, Truvada;   Drug: Darunavir, Ritonavir and Etravirine
8 Terminated A Safety and Immunogenicity Study of 3 Doses of Opal Immunotherapy in HIV Infected People
Condition: HIV Infections
Interventions: Biological: Opal-HIV-Gag(c) Low Dose;   Biological: Opal-HIV-Gag(c) Medium dose;   Biological: Opal-HIV-Gag(c) High dose;   Other: Dimethyl Sulfoxide
9 Recruiting Brief Intervention for Drug Misuse in the Emergency Department
Conditions: Substance Abuse Detection;   Acquired Immunodeficiency Syndrome;   Hepatitis B;   Hepatitis C;   Brief Intervention;   HIV Infections
Intervention: Behavioral: Brief motivational intervention
10 Recruiting Evaluation of Simplified Antiretroviral Treatment Strategies in HIV Infected Children Treated by Antiretroviral (ARV) Before One Year of Age
Condition: HIV Infections
Interventions: Drug: AZT-3TC-LPV/r twice a day;   Drug: ABC-3TC-EFV once a day
11 Completed Reducing Health Problems Associated With Injection Drug Use
Conditions: Intravenous Drug Abuse;   HIV Infections
Interventions: Behavioral: Skin and Needle Hygiene Intervention;   Other: No intervention - assessment-only condition
12 Unknown † Tenofovir Renal Toxicity and Glomerular Filtration Rate (GFR) Validation
Conditions: Renal Function;   HIV Infection
Intervention: Other: Tc99mDTPA renal clearance
13 Active, not recruiting Venue-Based Couples CoOp in South Africa
Conditions: Alcoholism;   HIV Infections
Interventions: Behavioral: Couples Intervention;   Behavioral: Women's CoOp;   Behavioral: Women's CoOp and Men's Intervention
14 Recruiting Stonewall Treatment Evaluation Project
Conditions: Substance Abuse;   HIV Infections
Intervention: Behavioral: Stonewall Project
15 Unknown † Pharmacokinetics (PK) and Safety of 2 Different Doses of Lopinavir/Ritonavir in in HIV/Tuberculosis (TB) Co-infected Patients Receiving Rifampicin Containing Anti-tuberculosis Therapy
Conditions: HIV Infections;   Tuberculosis
Intervention: Drug: LPV/r
16 Completed The Immunogenicity of Varicella-zoster Virus Vaccine in HIV-infected Children
Conditions: HIV Infections;   Varicella-Zoster Virus
Intervention: Biological: VZV vaccination
17 Recruiting Low Dose Atazanavir/r Versus Standard Dose Atazanavir/r (LASA)
Condition: HIV Infections
Intervention: Drug: ATV/r
18 Unknown † Pneumococcal Conjugate Vaccine (PCV) in HIV- Infected Children
Condition: Acquired Immunodeficiency Syndrome
Intervention: Biological: valent pneumococcal conjugated vaccine
19 Unknown † Lopinavir/Ritonavir (LPV/r) Tablet in HIV Infected Children
Condition: HIV-1 Infection
Intervention: Other: lopinavir/ritonavir
20 Terminated Novel Interventions in HIV-1 Infection
Condition: HIV-1 Infection
Interventions: Biological: GTU-MultiHIV B clade vaccine1mg;   Drug: Interleukin-2;   Drug: GM-CSF;   Drug: Growth Hormone
To Top

Previous Page Studies Shown (1-20) Next Page (21-32) Show next page of results
† Indicates status has not been verified in more than two years